These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8294487)

  • 1. Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression.
    Grace ME; Newman KM; Scheinker V; Berg-Fussman A; Grabowski GA
    J Biol Chem; 1994 Jan; 269(3):2283-91. PubMed ID: 8294487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.
    Grace ME; Graves PN; Smith FI; Grabowski GA
    J Biol Chem; 1990 Apr; 265(12):6827-35. PubMed ID: 2324100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms.
    Montfort M; Chabás A; Vilageliu L; Grinberg D
    Hum Mutat; 2004 Jun; 23(6):567-75. PubMed ID: 15146461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human acid beta-glucosidase. N-glycosylation site occupancy and the effect of glycosylation on enzymatic activity.
    Berg-Fussman A; Grace ME; Ioannou Y; Grabowski GA
    J Biol Chem; 1993 Jul; 268(20):14861-6. PubMed ID: 8325864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human acid beta-glucosidase: inhibition studies using glucose analogues and pH variation to characterize the normal and Gaucher disease glycon binding sites.
    Osiecki-Newman K; Legler G; Grace M; Dinur T; Gatt S; Desnick RJ; Grabowski GA
    Enzyme; 1988; 40(4):173-88. PubMed ID: 3234317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of asparagine 370 and glutamine 235 in the catalysis by acid beta-glucosidase: the enzyme deficient in Gaucher disease.
    Liou B; Grabowski GA
    Mol Genet Metab; 2009 May; 97(1):65-74. PubMed ID: 19217815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations.
    Liou B; Kazimierczuk A; Zhang M; Scott CR; Hegde RS; Grabowski GA
    J Biol Chem; 2006 Feb; 281(7):4242-53. PubMed ID: 16293621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient expression of wild-type and mutant glucocerebrosidases in hybrid vaccinia expression system.
    Hodanová K; Melková Z; Horowitz M; Hrebícek M
    Eur J Hum Genet; 2003 May; 11(5):369-74. PubMed ID: 12734541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease.
    Sun Y; Liou B; Xu YH; Quinn B; Zhang W; Hamler R; Setchell KD; Grabowski GA
    J Biol Chem; 2012 Feb; 287(6):4275-87. PubMed ID: 22167193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease.
    Xu YH; Quinn B; Witte D; Grabowski GA
    Am J Pathol; 2003 Nov; 163(5):2093-101. PubMed ID: 14578207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients.
    Grace ME; Desnick RJ; Pastores GM
    J Clin Invest; 1997 May; 99(10):2530-7. PubMed ID: 9153297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional characterization of mutated glucocerebrosidase alleles causing Gaucher disease in Spanish patients.
    Alfonso P; Rodríguez-Rey JC; Gañán A; Pérez-Calvo JI; Giralt M; Giraldo P; Pocoví M
    Blood Cells Mol Dis; 2004; 32(1):218-25. PubMed ID: 14757438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes.
    Grace ME; Berg A; He GS; Goldberg L; Horowitz M; Grabowski GA
    Am J Hum Genet; 1991 Sep; 49(3):646-55. PubMed ID: 1909090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants.
    Sun Y; Quinn B; Witte DP; Grabowski GA
    J Lipid Res; 2005 Oct; 46(10):2102-13. PubMed ID: 16061944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.
    Grace ME; Ashton-Prolla P; Pastores GM; Soni A; Desnick RJ
    J Clin Invest; 1999 Mar; 103(6):817-23. PubMed ID: 10079102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
    Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
    Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N370S (Asn370-->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C.
    Salvioli R; Tatti M; Scarpa S; Moavero SM; Ciaffoni F; Felicetti F; Kaneski CR; Brady RO; Vaccaro AM
    Biochem J; 2005 Aug; 390(Pt 1):95-103. PubMed ID: 15826241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease.
    Dvir H; Harel M; McCarthy AA; Toker L; Silman I; Futerman AH; Sussman JL
    EMBO Rep; 2003 Jul; 4(7):704-9. PubMed ID: 12792654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
    Qi X; Leonova T; Grabowski GA
    J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.